This statistic shows the number of new drugs receiving approval status in South Korea in 2014, by therapeutic category. In that year, a total of 33 new drugs were approved for use in South Korea, five of which were anti-cancer drugs.
Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Number of clinical trials for new drugs in South Korea 2010-2020
- Basic Statistic Pharmaceutical production value South Korea 2012-2022
- Premium Statistic Number of employees in the South Korean pharmaceutical industry 2019, by sector
- Basic Statistic Forecast major categories of U.S. healthcare expenditures 2015-2020
- Premium Statistic Number of medication brands that lose patent protection 2004-2020
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Premium Statistic Colorado medical and recreational marijuana sales 2014-2022
- Premium Statistic Expenditure for self-medication products in Italy 2013-2022
- Premium Statistic Expenditure for oncology drugs in Italy 2022, by category
- Premium Statistic Distribution of expenditure on cancer drugs in Italy 2020, by type
About the region
10
- Premium Statistic New pharmaceutical drugs in R&D pipelines in South Korea 2014, by therapeutic area
- Premium Statistic OTC drug products production value South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2012-2022
- Premium Statistic Number of pharmaceutical distributors South Korea 2012-2022
- Premium Statistic Number of pharmaceutical distributors South Korea 2022, by type
- Premium Statistic Therapeutic sectors for drug products South Korea 2019, by production value
- Premium Statistic Prescription drug products production value South Korea 2012-2022
- Premium Statistic Leading pharmaceutical companies South Korea 2022, by production value
Selected statistics
7
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Premium Statistic Pfizer's ad spending 2006-2023
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
- Premium Statistic Enterprise and brand value of Shoppers Drug Mart in 2012
Other regions
10
- Premium Statistic U.S. drug development phase I to approval success rates 2011-2020 by disease area
- Basic Statistic Number of NAS approved by Health Canada 2014-2021
- Basic Statistic Distribution pharmacy revenues in Denmark by product type 2022
- Basic Statistic Price disparities for Spiriva Handihaler - U.S. and international 2024
- Premium Statistic Average CAGR of pharmaceutical spending in Asia 2013-2017, by country
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic VECOL S.A.: net sales breakdown 2016-2018, by segment
- Basic Statistic Expenditure on innovative cancer drugs in Italy 2020, by region
- Basic Statistic Expenditure on pharmaceutical products in the United Kingdom 2005-2022
- Premium Statistic LabCorp revenues 2013-2023
Related statistics
10
- Premium Statistic Leading pharmaceutical products South Korea 2022, by production value
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Global pharmaceutical pipeline by therapy area 2013-2017
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Global pharmaceutical pipeline by therapy area 2013-2017
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
Korea Drug Research Association. (July 16, 2016). Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category [Graph]. In Statista. Retrieved March 29, 2024, from https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/
Korea Drug Research Association. "Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category ." Chart. July 16, 2016. Statista. Accessed March 29, 2024. https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/
Korea Drug Research Association. (2016). Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category . Statista. Statista Inc.. Accessed: March 29, 2024. https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/
Korea Drug Research Association. "Number of New Drugs Receiving Approval Status in South Korea in 2014, by Therapeutic Category ." Statista, Statista Inc., 16 Jul 2016, https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/
Korea Drug Research Association, Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category Statista, https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/ (last visited March 29, 2024)
Number of new drugs receiving approval status in South Korea in 2014, by therapeutic category [Graph], Korea Drug Research Association, July 16, 2016. [Online]. Available: https://www.statista.com/statistics/646536/new-drug-approvals-south-korea-by-therapy-area/